Paloma Partners’s Arcadia Biosciences RKDA Stock Holding History

Paloma Partners’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-39	Closed	-$81K	–	2078
2016 Q2	$81K	Buy	+39	New	+$65.3K	﹤0.01%	2085

Other funds holding RKDA

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

LRPA

L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Paloma Partners's RKDA Position: Q3 2016 in Review

Paloma Partners sold out of Arcadia Biosciences (RKDA) in Q3 2016, closing a stake of 39 shares — an estimated $81K sold.

Paloma Partners first reported a position in RKDA in Q2 2016 and held it in 1 quarter. The position peaked at $81K in Q2 2016. 16 funds tracked by Wall St. Rank hold RKDA as of Q3 2016.

Paloma Partners reported no remaining Arcadia Biosciences position as of Q3 2016 after selling out during the quarter.
Paloma Partners sold 39 Arcadia Biosciences shares in Q3 2016, an estimated $81K.
Paloma Partners first reported a position in Arcadia Biosciences in Q2 2016 and held it in 1 quarter.
Paloma Partners's Arcadia Biosciences position peaked at $81K in Q2 2016.
16 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q3 2016.

Based on Paloma Partners's 13F filing for Q3 2016, filed 14 Nov 2016.